Literature DB >> 15562197

Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife.

Susan A Everson-Rose1, Peter M Meyer, Lynda H Powell, Dilip Pandey, Javier I Torréns, Howard M Kravitz, Joyce T Bromberger, Karen A Matthews.   

Abstract

OBJECTIVE: To examine depression and 3-year change in insulin resistance and risk of diabetes and whether associations vary by race. RESEARCH DESIGN AND METHODS: We analyzed data from 2,662 Caucasian, African-American, Hispanic, Japanese-American, and Chinese-American women without a history of diabetes from the Study of Women's Health Across the Nation. We estimated regression coefficients and odds ratios to determine whether depression (Center for Epidemiological Studies Depression Scale score > or =16) predicted increases in homeostasis model assessment of insulin resistance (HOMA-IR) and greater risk of incident diabetes, respectively, over 3 years.
RESULTS: Mean baseline HOMA-IR was 1.31 (SD 0.86) and increased 0.05 units per year for all women (P <0.0001). A total of 97 incident cases of diabetes occurred. Depression was associated with absolute levels of HOMA-IR (P <0.04) but was unrelated to changes in HOMA-IR; associations did not vary by race. The association between depression and HOMA-IR was eliminated after adjustment for central adiposity (P=0.85). Depression predicted a 1.66-fold greater risk of diabetes (P <0.03), which became nonsignificant after adjustment for central adiposity (P=0.12). We also observed a depression-by-race interaction (P <0.05) in analyses limited to Caucasians and African Americans, the only groups with enough diabetes cases to reliably test this interaction. Race-stratified models showed that depression predicted 2.56-fold greater risk of diabetes in African Americans only, after risk factor adjustment (P=0.008).
CONCLUSIONS: Depression is associated with higher HOMA-IR values and incident diabetes in middle-aged women. These associations are mediated largely through central adiposity. However, African-American women with depression experience increased risk of diabetes independent of central adiposity and other risk factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15562197     DOI: 10.2337/diacare.27.12.2856

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  72 in total

1.  The effect of a 4-week treatment with reboxetine on metabolic parameters of depressed inpatients.

Authors:  Georgios Paslakis; Maria Gilles; Florian Lederbogen; Claudia Schilling; Barbara Scharnholz; Michael Deuschle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-30       Impact factor: 5.270

Review 2.  A clinical prescription for heart health in midlife women.

Authors:  Chrisandra Shufelt; Erika Dutra; Tina Torbati; Tina Ramineni
Journal:  Maturitas       Date:  2018-11-12       Impact factor: 4.342

Review 3.  Posttraumatic stress disorder, cardiovascular, and metabolic disease: a review of the evidence.

Authors:  Eric A Dedert; Patrick S Calhoun; Lana L Watkins; Andrew Sherwood; Jean C Beckham
Journal:  Ann Behav Med       Date:  2010-02

4.  Type 2 diabetes does not increase risk of depression.

Authors:  Lauren C Brown; Sumit R Majumdar; Stephen C Newman; Jeffrey A Johnson
Journal:  CMAJ       Date:  2006-07-04       Impact factor: 8.262

5.  Effect of a selective cyclooxygenase type 2 inhibitor celecoxib on depression associated with obesity in mice: an approach using behavioral tests.

Authors:  Yeshwant Kurhe; Radhakrishnan Mahesh; Deepali Gupta
Journal:  Neurochem Res       Date:  2014-05-11       Impact factor: 3.996

6.  Examining a bidirectional association between depressive symptoms and diabetes.

Authors:  Sherita Hill Golden; Mariana Lazo; Mercedes Carnethon; Alain G Bertoni; Pamela J Schreiner; Ana V Diez Roux; Hochang Benjamin Lee; Constantine Lyketsos
Journal:  JAMA       Date:  2008-06-18       Impact factor: 56.272

7.  Associations between central nervous system serotonin, fasting glucose, and hostility in African American females.

Authors:  Stephen H Boyle; Anastasia Georgiades; Beverly H Brummett; John C Barefoot; Ilene C Siegler; Wayne R Matson; Cynthia M Kuhn; Katherine Grichnik; Mark Stafford-Smith; Redford B Williams; Rima Kaddurah-Daouk; Richard S Surwit
Journal:  Ann Behav Med       Date:  2015-02

8.  Recent advances in understanding depression in adults with diabetes.

Authors:  Patrick J Lustman; Sue M Penckofer; Ray E Clouse
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

Review 9.  [Depression and diabetes mellitus type 2].

Authors:  M Deuschle; U Schweiger
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

10.  Interactive effects of race and depressive symptoms on calcification in African American and white women.

Authors:  Tené T Lewis; Susan A Everson-Rose; Alicia Colvin; Karen Matthews; Joyce T Bromberger; Kim Sutton-Tyrrell
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.